ArticleJournal of medicinal chemistry2011

Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease.

David S Snyder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.